You are treating AM, a 28 y/o female with no allergies, who has a repeat diagnosis of UTI within the last 4 months. She has systemic symptoms. You have concerns for antimicrobial resistance patterns for treating UTIs in your community. Which of the following is an appropriate therapy option for AM?

Recurrent urinary tract infections (UTIs) with systemic symptoms suggest a more complicated infection, possibly involving upper urinary tract involvement such as pyelonephritis or resistant organisms. Treatment selection must consider local antimicrobial resistance patterns, severity of symptoms, and prior antibiotic exposure. Broader-spectrum antibiotics are often required when resistance is a concern or when infection is not limited to the lower urinary tract. Therapy duration is also extended in more complex presentations. Rationale: A. Ciprofloxacin (Cipro) is an appropriate option in this scenario because it provides broad-spectrum coverage against common urinary pathogens and achieves good tissue penetration, including renal tissue. In a patient with recurrent UTI and systemic symptoms, there is concern for resistant organisms or upper tract involvement, making fluoroquinolones a reasonable choice when resistance patterns support their use. A 7-day course is consistent with treatment for complicated infection. B. Trimethoprim-sulfamethoxazole (Bactrim) is typically used for uncomplicated cystitis with a short 3-day course when local resistance rates are low. However, in recurrent infections with systemic symptoms and concern for resistance, it may be ineffective due to increasing E. coli resistance. It is not the best empiric choice in this higher-risk presentation. C. Clarithromycin (Biaxin) is not appropriate for urinary tract infections because it has poor activity against common uropathogens such as E. coli. Macrolides are primarily used for respiratory and certain atypical infections, not urinary tract infections. Therefore, it would not provide adequate empiric coverage in this case. D. Fosfomycin (Monurol) is used as a single-dose therapy for uncomplicated lower urinary tract infections. It is not appropriate for recurrent UTIs with systemic symptoms or suspected upper urinary tract involvement. Its limited systemic penetration makes it unsuitable for more complicated or resistant infections.